• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鲍曼不动杆菌呼吸机相关性肺炎:流行病学、临床特征和预后因素。

Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.

机构信息

Intensive Care Unit, Faculty of Medicine, University of Sfax, Hôpital Habib Bourguiba, Route el Ain Km 1, 3029 Sfax, Tunisia.

出版信息

Int J Infect Dis. 2013 Dec;17(12):e1225-8. doi: 10.1016/j.ijid.2013.07.014. Epub 2013 Sep 11.

DOI:10.1016/j.ijid.2013.07.014
PMID:24094525
Abstract

OBJECTIVE

The aim of this study was to describe the epidemiological characteristics of Acinetobacter baumannii ventilator-associated pneumonia (VAP) and to identify factors predictive of a poor outcome.

METHODS

A retrospective study was conducted over 16 months in a Tunisian intensive care unit (ICU). All adult patients with A. baumannii VAP were included.

RESULTS

Ninety-two patients were included in they study; 41 (44.6%) were admitted because of multiple trauma. The mean age of the patients was 44.5±19.5 years. All patients needed mechanical ventilation on admission. The mean SAPS II score was 39±15. The mean delay before VAP onset was 8.1±4.7 days. On VAP onset, 57 patients (62%) developed septic shock. Only 14.2% of isolated strains were susceptible to imipenem; none were resistant to colistin. The mean duration of mechanical ventilation was 20±11 days. The mean duration of ICU stay was 24.3±18.7 days. ICU mortality was 60.9%. In the multivariate analysis, factors predictive of a poor outcome were previously known hypertension (odds ratio 5.8, 95% confidence interval 1.4-24.9; p=0.018) and VAP-related septic shock (odds ratio 8.5, 95% confidence interval 3-23.7; p<0.001).

CONCLUSION

A. baumannii VAP is associated with a high mortality. Hemodynamic impairment is predictive of a poor outcome.

摘要

目的

本研究旨在描述鲍曼不动杆菌呼吸机相关性肺炎(VAP)的流行病学特征,并确定预后不良的预测因素。

方法

在突尼斯的一个重症监护病房(ICU)进行了为期 16 个月的回顾性研究。所有鲍曼不动杆菌 VAP 成年患者均被纳入研究。

结果

共有 92 例患者纳入研究,其中 41 例(44.6%)因多发伤入院。患者的平均年龄为 44.5±19.5 岁。所有患者入院时均需机械通气。SAPS II 评分的平均值为 39±15。VAP 发病前的平均时间为 8.1±4.7 天。VAP 发病时,57 例患者(62%)发生感染性休克。只有 14.2%的分离株对亚胺培南敏感;无耐药菌株对粘菌素耐药。机械通气的平均持续时间为 20±11 天。ICU 住院的平均时间为 24.3±18.7 天。ICU 死亡率为 60.9%。在多变量分析中,预后不良的预测因素包括既往已知的高血压(比值比 5.8,95%置信区间 1.4-24.9;p=0.018)和与 VAP 相关的感染性休克(比值比 8.5,95%置信区间 3-23.7;p<0.001)。

结论

鲍曼不动杆菌 VAP 死亡率较高。血流动力学障碍是预后不良的预测因素。

相似文献

1
Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.鲍曼不动杆菌呼吸机相关性肺炎:流行病学、临床特征和预后因素。
Int J Infect Dis. 2013 Dec;17(12):e1225-8. doi: 10.1016/j.ijid.2013.07.014. Epub 2013 Sep 11.
2
Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.在治疗铜绿假单胞菌和鲍曼不动杆菌呼吸机相关性肺炎时,使用辅助雾化抗菌治疗。
Respir Care. 2012 Aug;57(8):1226-33. doi: 10.4187/respcare.01556. Epub 2012 Feb 17.
3
Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.雾化黏菌素治疗多重耐药鲍曼不动杆菌肺炎:台湾北部一家三级医院的经验。
J Microbiol Immunol Infect. 2010 Aug;43(4):323-31. doi: 10.1016/S1684-1182(10)60050-3.
4
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.多黏菌素联合治疗广泛耐药鲍曼不动杆菌肺炎。
Int J Antimicrob Agents. 2014 Apr;43(4):378-82. doi: 10.1016/j.ijantimicag.2014.01.016. Epub 2014 Feb 14.
5
Ventilator-Associated Pneumonia due to Drug-Resistant : Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality.耐药性导致的呼吸机相关性肺炎:危险因素、与耐药谱的死亡率关系以及院内死亡的独立预测因素
Medicina (Kaunas). 2019 Feb 13;55(2):49. doi: 10.3390/medicina55020049.
6
[Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].[多黏菌素在泛耐药铜绿假单胞菌和鲍曼不动杆菌所致呼吸机相关性肺炎中的应用]
Mikrobiyol Bul. 2009 Jan;43(1):61-70.
7
Candida spp. airway colonization: A potential risk factor for Acinetobacter baumannii ventilator-associated pneumonia.念珠菌属气道定植:鲍曼不动杆菌呼吸机相关性肺炎的一个潜在危险因素。
Med Mycol. 2016 Aug 1;54(6):557-66. doi: 10.1093/mmy/myw009. Epub 2016 Mar 21.
8
Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes.广泛耐药鲍曼不动杆菌引起的呼吸机相关性肺炎:危险因素、临床特征和结局。
Am J Infect Control. 2014 Feb;42(2):206-8. doi: 10.1016/j.ajic.2013.09.003.
9
Pre-intensive care unit intubation and subsequent delayed intensive care unit admission is independently associated with increased occurrence of ventilator-associated pneumonia.重症监护病房前插管及随后延迟入住重症监护病房与呼吸机相关性肺炎发生率增加独立相关。
Clin Respir J. 2018 Oct;12(10):2497-2504. doi: 10.1111/crj.12944. Epub 2018 Sep 23.
10
Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.泰国某大学医院医学重症监护病房中多重耐药、广泛耐药及泛耐药鲍曼不动杆菌呼吸机相关性肺炎的危险因素
J Infect Chemother. 2015 Aug;21(8):570-4. doi: 10.1016/j.jiac.2015.04.010. Epub 2015 May 7.

引用本文的文献

1
Hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19.由多重耐药革兰氏阴性病原体引起的医院获得性肺炎和呼吸机相关性肺炎:了解流行病学、耐药模式以及与COVID-19的关联
F1000Res. 2024 Mar 25;12:92. doi: 10.12688/f1000research.129080.1. eCollection 2023.
2
Using time-series chest radiographs and laboratory data by machine learning for identifying pulmonary infection and colonization of Acinetobacter baumannii.利用时间序列胸部 X 光片和机器学习的实验室数据来识别肺部感染和鲍曼不动杆菌定植。
Respir Res. 2024 Jan 3;25(1):2. doi: 10.1186/s12931-023-02624-x.
3
Carbapenem-Resistant spp Infection in Critically Ill Patients With Limited Treatment Options: A Descriptive Study of Cefiderocol Therapy During the COVID-19 Pandemic.
治疗选择有限的重症患者中的耐碳青霉烯类菌感染:COVID-19大流行期间头孢地尔治疗的描述性研究
Open Forum Infect Dis. 2023 Jul 4;10(7):ofad329. doi: 10.1093/ofid/ofad329. eCollection 2023 Jul.
4
Natural Antibodies Mediate Protection Against Acinetobacter baumannii Respiratory Infections.天然抗体介导对鲍曼不动杆菌呼吸道感染的保护。
J Infect Dis. 2023 Aug 11;228(3):353-363. doi: 10.1093/infdis/jiad069.
5
Molecular Characterization and Antibiogram of Clinical Isolates Recovered from the Patients with Ventilator-Associated Pneumonia.从呼吸机相关性肺炎患者中分离出的临床分离株的分子特征及药敏谱
Healthcare (Basel). 2022 Nov 3;10(11):2210. doi: 10.3390/healthcare10112210.
6
Droperidol as a potential inhibitor of acyl-homoserine lactone synthase from A. baumannii: insights from virtual screening, MD simulations and MM/PBSA calculations.鲍曼不动杆菌酰高丝氨酸内酯合酶的虚拟筛选、分子动力学模拟和 MM/PBSA 计算研究发现,氟哌利多可能是其抑制剂。
Mol Divers. 2023 Oct;27(5):1979-1999. doi: 10.1007/s11030-022-10533-2. Epub 2022 Oct 3.
7
Oral colonization of in intensive care units: Risk factors, incidence, molecular epidemiology, association with the occur of pneumonia and sepsis, and infection control measures.重症监护病房中的口腔定植:危险因素、发生率、分子流行病学、与肺炎和脓毒症发生的关联以及感染控制措施。
Iran J Basic Med Sci. 2022 Feb;25(2):239-244. doi: 10.22038/IJBMS.2022.59713.13243.
8
Synergistic Inhibitory Effect of Polymyxin B in Combination with Ceftazidime against Robust Biofilm Formed by Acinetobacter baumannii with Genetic Deficiency in AbaI/AbaR Quorum Sensing.多黏菌素 B 与头孢他啶联合用药对具有 AbaI/AbaR 群体感应基因缺陷的鲍曼不动杆菌形成的坚固生物膜的协同抑制作用。
Microbiol Spectr. 2022 Feb 23;10(1):e0176821. doi: 10.1128/spectrum.01768-21.
9
Antibiotic resistance in hospital-acquired ESKAPE-E infections in low- and lower-middle-income countries: a systematic review and meta-analysis.低及中低收入国家医院获得性 ESKAPE-E 感染中的抗生素耐药性:系统评价和荟萃分析。
Emerg Microbes Infect. 2022 Dec;11(1):443-451. doi: 10.1080/22221751.2022.2030196.
10
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.挽救四环素类抗生素治疗多重耐药鲍曼不动杆菌肺部感染。
mBio. 2022 Feb 22;13(1):e0351721. doi: 10.1128/mbio.03517-21. Epub 2022 Jan 11.